Terns Pharmaceuticals
Why Robinhood?
You can watch TERN and buy or sell other stocks, ETFs, and their options commission-free!About TERN
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program.
TERN Key Statistics
Stock Snapshot
Terns Pharmaceuticals(TERN) stock is priced at $52.95, giving the company a market capitalization of 6.12B. It carries a P/E multiple of -51.28.
On 2026-05-06, Terns Pharmaceuticals(TERN) stock opened at —, reached a high of —, and a low of —.
The Terns Pharmaceuticals(TERN)'s current trading volume is 0, compared to an average daily volume of 2.97M.
In the last year, Terns Pharmaceuticals(TERN) shares hit a 52-week high of $53.19 and a 52-week low of $2.66.
In the last year, Terns Pharmaceuticals(TERN) shares hit a 52-week high of $53.19 and a 52-week low of $2.66.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.